New Mexico Administrative Code › Title 8 - SOCIAL SERVICES › Chapter 321 - SPECIALIZED BEHAVIORAL HEALTH SERVICES › Part 10 - OPIOID TREATMENT PROGRAMS › Section 8.321.10.18 - ADMINISTRATION

Current through Register Vol. 35, No. 13, July 16, 2024
The program sponsor shall ensure that:
A. a physician licensed to practice in New
				Mexico is designated to serve as medical director and to have authority over
				all medical aspects of opioid treatment;
B. the medical director is responsible for
				ensuring that the OTP is in compliance with all applicable federal, state and
				local laws and regulations;
C. the
				OTP shall be open for patients every day of the week except for federal and
				state holidays, and Sundays, and be closed only as allowed in advance in
				writing by CSAT and the state methadone authority;
D. written policies and procedures are
				developed, implemented, complied with and maintained at the OTP and include:
(1) procedures to prevent a patient from
				receiving opioid dependency treatment from more than one agency or physician
				concurrently;
(2) procedures to
				meet the unique needs of diverse populations, such as pregnant women, children,
				individuals with communicable diseases, (e.g. hepatitis C, tuberculosis, HIV or
				AIDS), or individuals involved in the criminal justice system;
(3) procedures for conducting a physical
				examination, assessment and laboratory tests;
(4) procedures for establishing substance
				abuse counselor caseloads, based on the intensity and duration of counseling
				required by each patient;
(5)
				criteria for when the patient's blood serum levels should be tested and
				procedures for having the test performed;
(6) procedures for performing laboratory
				tests, such as urine drug screens or toxicological tests, including procedures
				for collecting specimens for testing;
(7) procedures for addressing and managing a
				patient's concurrent use of alcohol or other drugs;
(8) procedures for providing take home
				medication to patients;
(9)
				procedures for conducting opioid treatment withdrawal;
(10) procedures for conducting an
				administrative withdrawal;
(11)
				procedures for voluntary discharge, including a requirement that a patient
				discharged voluntarily be provided or offered follow-up services, such as
				counseling or a referral for medical treatment;
(12) procedures for making temporary or
				permanent transfer of a patient from the OTP to another OTP;
(13) procedures for receiving the temporary
				or permanent transfer of a patient from another OTP to the OTP;
(14) procedures to minimize the following
				adverse events:
(a) a patient's loss of
				ability to function;
(b) a
				medication error;
(c) harm to a
				patient's family member or another individual resulting from ingesting a
				patient's medication;
(d) sales of
				illegal drugs on the premises;
(e)
				diversion of a patient's medication;
(f) harassment or abuse of a patient by a
				staff member or another patient; and
(g) violence on the premises;
(15) procedures to respond to an
				adverse event, including:
(a) a requirement
				that the program sponsor immediately investigate the adverse event and the
				surrounding circumstances;
(b) a
				requirement that the program sponsor develop and implement a plan of action to
				prevent a similar adverse event from occurring in the future; monitor the
				action taken; and take additional action, as necessary, to prevent a similar
				adverse event;
(c) a requirement
				that action taken under the plan of action be documented; and
(d) a requirement that the documentation be
				maintained at the agency for at least two years after the date of the adverse
				event;
(16) procedures
				for infection control;
(17)
				criteria for determining the amount and frequency of counseling that is
				provided to a patient; procedures to ensure that the facility's physical
				appearance is clean and orderly;
(18) a process for resolution of patient
				complaints, including a provision that complaints which cannot be resolved
				through the clinic's process may be referred by either party to the HCA:
(a) the complaint process shall be explained
				to the patient at admission;
(b)
				the patient complaint process shall be posted prominently in its waiting area
				or other location where it will be easily seen by patients, and include the HCA
				contact information for use in the event that the complaint cannot be resolved
				through the clinic's process.